Get the Stockscreener App
0.2196
5.53%
0.0115
Pre-market:
.21
-0.0096
-4.37%
Incannex Healthcare Inc stock is traded at $0.2196, with a volume of 31.53M.
It is up +5.53% in the last 24 hours and down -15.54% over the past month.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
See More
Previous Close:
$0.2081
Open:
$0.21
24h Volume:
31.53M
Relative Volume:
0.62
Market Cap:
$19.86M
Revenue:
-
Net Income/Loss:
$-21.91M
P/E Ratio:
-0.1474
EPS:
-1.49
Net Cash Flow:
-
1W Performance:
+3.58%
1M Performance:
-15.54%
6M Performance:
-88.52%
1Y Performance:
-93.46%
1-Day Range:
$0.2046
$0.2199
1-Week Range:
$0.1888
$0.2616
52-Week Range:
$0.08
$3.55
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare Inc
Sector
Phone
61 409 840 786
Address
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.2196 | 19.86M | 0 | -21.91M | 0 | -1.49 |
|
RGC
Regencell Bioscience Holdings Ltd
|
78.00 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
161.67 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.50 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.89 | 47.60B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Incannex Healthcare Inc Stock (IXHL) Latest News
Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com
Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com Nigeria
Incannex Healthcare Announces Psychedelic Therapies Joint Venture - TipRanks
Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - marketscreener.com
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times
Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq
Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan
Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules By Investing.com - Investing.com Canada
Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules - Investing.com
Incannex Healthcare Transfers Listing to Nasdaq Capital Market - TipRanks
Incannex Healthcare Cancels Series A Warrants - TipRanks
Incannex Cancels All Warrants, Removes 347M Share Dilution Before Critical Sleep Apnea Trial Data - Stock Titan
Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - Revista ADVFN
Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - mx.advfn.com
Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - mx.advfn.com
Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - mx.advfn.com
Incannex Expands Advisory Board for OSA Program - TipRanks
Incannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Nasdaq
Harvard and Emory Leaders Join Incannex's Sleep Apnea Program Ahead of Critical Phase 2 Data - Stock Titan
Cannabis Stocks To Add to Your Watchlist – May 29th - Defense World
Incannex advances to phase 3 trial for sleep apnea treatment By Investing.com - Investing.com South Africa
Cannabis Stocks To ResearchMay 25th - MarketBeat
Cannabis Stocks To Consider – May 28th - Defense World
Incannex Healthcare Advances RePOSA Trial to Phase 3 - TipRanks
Incannex advances to phase 3 trial for sleep apnea treatment - Investing.com Australia
Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance - marketscreener.com
Breakthrough: FDA Green-Lights Phase 3 Trial for Revolutionary Oral Sleep Apnea Treatment - Stock Titan
Incannex cancels remaining Series A Warrants to reduce dilution By Investing.com - Investing.com South Africa
Promising Cannabis Stocks Worth Watching – May 27th - Defense World
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - BioSpace
Incannex Cancels Series A Warrants to Strengthen Capital - TipRanks
Incannex cancels remaining Series A Warrants to reduce dilution - Investing.com
Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - The Manila Times
Incannex Cancels 347M Share Warrant Dilution Before Crucial Sleep Apnea Drug Data Release - Stock Titan
Incannex Healthcare Amends ATM Sales Agreement - TipRanks
SEC Form 424B5 filed by Incannex Healthcare Inc. - Quantisnow
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Cannabis Stocks To Research – May 25th - Defense World
Cannabis Stocks To Follow NowMay 24th - MarketBeat
Cannabis Stocks To Follow Now – May 24th - Defense World
Best Cannabis Stocks To Follow Now – May 23rd - Defense World
Top Cannabis Stocks To Keep An Eye On – May 22nd - Defense World
Best Cannabis Stocks To Watch TodayMay 18th - MarketBeat
Top Cannabis Stocks To Follow Now – May 20th - Defense World
Cannabis Stocks To Follow Today – May 19th - Defense World
Incannex's Big Leap Forward With Obstructive Sleep Apnea Study - Finimize
Incannex Healthcare boosts share offering capacity By Investing.com - Investing.com Nigeria
Incannex Cancels Warrants to Strengthen Shareholder Position - TipRanks
Incannex Healthcare boosts share offering capacity - Investing.com
Incannex Healthcare Expands Share Issuance Agreement - TipRanks
Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution - The Manila Times
Incannex Healthcare Inc Stock (IXHL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):